Volume: January 2024, Issue 1

Jan 31, 2024 | Hot Topics

AARS News

  • Register Now to Connect with the AARS in San Diego on March 8, 2024!

  • Save the Date: 11th Annual AARS Scientific Symposium


New Medical Research

  • Acne vulgaris: Clinical aspects and treatments.

  • Efficacy and safety of solid-state dual-wavelength lasers for the treatment of moderate-to-severe inflammatory acne in Asian populations.

  • Evaluation of DermSat-7 for assessing treatment satisfaction in patients with acne.
  • Efficacy and safety of fractional microneedle radiofrequency for atrophic acne scars: A real-world clinical study of 126 patients.

  • Integrative bioinformatics and experimental validation of hub genetic markers in acne vulgaris: Toward personalized diagnostic and therapeutic strategies.

  • Peiminine exerts its anti-acne effects by regulating the NF-κB pathway.

  • Antimicrobial properties related to anti-acne and deodorant efficacy of hedychium coronarium j. koenig extracts from pulsed electric field extraction.

  • Real-world adverse events associated with encapsulated benzoyl peroxide/tretinoin, 3%/0.1%, and encapsulated benzoyl peroxide, 5.

  • Neutrophil extracellular trap-related mechanisms in acne vulgaris inspire a novel treatment strategy with adipose-derived stem cells.

  • Resolving acne with optimized adapalene microspongeal gel, in vivo and clinical evaluations.

  • Long-term efficacy and safety of nonablative monopolar radiofrequency in the treatment of moderate to severe acne vulgaris.

  • Practice and attitude of general practitioners towards initiating isotretinoin for acne vulgaris in Fars province, Iran: cross-sectional study.

  • Comprehensive assessment of the efficacy and safety of a clay mask in oily and acne skin.
  • Lactobacillus plantarum MH-301 as an effective adjuvant to isotretinoin in the treatment of acne vulgaris: A randomized and open-label trial.

  • Lactobacillus rhamnosus ameliorates acne vulgaris in SD rats via changes in gut microbiota and associated tryptophan metabolism.

  • The antibacterial activity of berberine against cutibacterium acnes: Its therapeutic potential in inflammatory acne.

  • Integrated short-term and long-term efficacy of topical clascoterone cream 1% in patients aged 12 years or older with acne vulgaris.

  • A novel predictive method for risk stratification in acne patients receiving isotretinoin: An analysis of laboratory abnormalities and changes in inflammatory parameters.


Clinical Reviews

  • 1726 nm lasers for the treatment of acne vulgaris.

  • Tumor necrosis factor-α inhibitor treatment of acne fulminans – a clinical and literature review.

  • A review of the dermatologic clinical applications of topical photodynamic therapy.

  • Needle-free jet injection of poly-(lactic acid) for atrophic acne scars: Literature review and report of clinical cases.

  • A review of the diagnostic and therapeutic gaps in rosacea management: Consensus opinion.

  • The cutaneous effects of androgens and androgen-mediated sebum production and their pathophysiologic and therapeutic importance in acne vulgaris.

  • The microbiome and acne: Perspectives for treatment.

  • The primary role of sebum in the pathophysiology of acne vulgaris and its therapeutic relevance in acne management.

Related Posts

Volume: July 2024, Issue 1

Volume: July 2024, Issue 1

AARS News AARS July Membership Discount Available to HCPs Amid Paucity of Innovation, New Acne Treatment Guidelines Overlook Critical Issues: Editorial AARS Spotlights #AcneFacts During National Acne Awareness Month AARS Goes One-on-One with Dermatologist Sandra Lee,...

Volume: June 2024, Issue 1

Volume: June 2024, Issue 1

AARS News   Highlights from the 11th Annual AARS Annual Scientific Symposium New Medical Research Isotretinoin for acne in transgender and gender-diverse individuals receiving masculinizing hormone therapy. Efficacy and safety of bimekizumab in patients with...

Volume: May 2024, Issue 1

Volume: May 2024, Issue 1

AARS News   AARS Call for Grant Applications New Medical Research Triple combination clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% for acne: Efficacy and safety from a pooled phase 3 analysis. The role of vitamins and nutrients in rosacea....

Volume: July 2024, Issue 1

Volume: April 2024, Issue 1

AARS News   Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products New Medical...